D-Cell 360 automated haematology analyzer Μαυροβούνιο - Κροατικά - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

d-cell 360 automated haematology analyzer

druŠtvo sa ograniČenom odgovornoŠĆu "farmalab" d.o.o. podgorica - in vitro dijagnostička medicinska sredstva

UF-1500 Fully Automated Urine Particle Analyzer Μαυροβούνιο - Κροατικά - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

uf-1500 fully automated urine particle analyzer

"yunycom" d.o.o., beograd - dio druŠtva "yunycom-montenegro" herceg novi - in vitro dijagnostička medicinska sredstva

Immulite 20002000 XPI System (Automated Immunoassay Analyzer) Μαυροβούνιο - Κροατικά - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

immulite 20002000 xpi system (automated immunoassay analyzer)

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - in vitro dijagnostička medicinska sredstva

Fully Automated Urine Particle Analyser Model: UF-4000 UF-5000 Μαυροβούνιο - Κροατικά - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

fully automated urine particle analyser model: uf-4000 uf-5000

"yunycom" d.o.o., beograd - dio druŠtva "yunycom-montenegro" herceg novi - in vitro dijagnostička medicinska sredstva

XQ-Series Automated Hematology Analyzer Model: XQ-520 Μαυροβούνιο - Κροατικά - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

xq-series automated hematology analyzer model: xq-520

"yunycom" d.o.o., beograd - dio druŠtva "yunycom-montenegro" herceg novi - in vitro dijagnostička medicinska sredstva

Cevenfacta Ευρωπαϊκή Ένωση - Κροατικά - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

Vacusera Pressure Activated Safety Lancet Model: 2393018N 2392118N Μαυροβούνιο - Κροατικά - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

vacusera pressure activated safety lancet model: 2393018n 2392118n

trgovaČko druŠtvo sa ograniČenom odgovornoŠĆu "danlab" d.o.o., podgorica - medicinska sredstva za jednokratnu upotrebu

Coxevac Ευρωπαϊκή Ένωση - Κροατικά - EMA (European Medicines Agency)

coxevac

ceva santé animale - inaktiviran coxiella burnetii cjepivo, soj nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.